Your search for comorbidities returned 71 results

The long-term risk for a venous thromboembolism event was found to be associated with the occurrence of heart failure with preserved or reduced ejection fraction, and with left ventricular remodeling.

The presence of hyperlipidemia following hospitalization for acute myocardial infarction or acute decompensated heart failure may be associated with reduced mortality.

Patients with vs without chronic kidney disease were found to have more comorbidities and complex lesions after receiving new-generation drug-eluting stents.

Left atrial enlargement with vs without atrial fibrillation was not found to be associated with greater cognitive decline over a 5-year period.

The incidence of patients who are not responsive to cardiac resynchronization therapy was found to be high.

The study did not observe any clinically relevant association between use of antihypertensive drugs and pancreatic cancer risk in patients with chronic pancreatitis.

Researchers investigated and compared the rates, risks, and risk factors for atrial fibrillation among Medicaid recipients with systemic lupus erythematosus (SLE) and age- and sex-matched Medicaid recipients without SLE.

In patients with heart failure with preserved ejection fraction, pulmonary disease may be an independent predictor of all-cause and heart failure hospitalizations.

Advanced interatrial block is a favorable parameter to estimate the presence of low voltage area and it may provide useful information for the treatment strategy for atrial fibrillation and the prediction of the outcome after ablation.

Patients with monitoring device like pacemaker had a significantly increased risk of being diagnosed with AF in comparison to general population with no difference in incidence of AF when 2 different monitoring devices were compared.